Category III CPT code application update
Filed with ASX · · 2 pages · English
Summary by 6ix AI
EchoIQ Limited provides an update on its application for a Category III CPT code for EchoSolv AS, which was unsuccessful according to the American Medical Association's recent decision. The company is evaluating options for reimbursement and may request reconsideration of the decision within a specified timeframe. EchoIQ is also engaging with the AMA regarding new CPT codes for AI technologies, which are expected to be implemented in the near future. The CEO expressed confidence in ongoing regulatory engagement and the potential for future reimbursement opportunities.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from EchoIQ
- Trading Halt
- Pause in Trading
- Strong Operational Momentum
- Update on Category III CPT Code Application
- Preliminary Final Report
Later from EchoIQ
- Quarterly Activities and Appendix 4C Cash Flow Report
- Echo IQ Highlights Market Potential for EchoSolv AS Following Presentation of New Data for Severe Aortic Stenosis (AS) Presented at AHA Scientific Sessions 2025
- Echo IQ to Participate in the Piper Sandler 37th Annual Healthcare Conference
- Exceptional Results from Validation Study for EchoSolv HF
- Validation study for EchoSolv HF completed at the Mayo Clinic – Study delivers exceptional results
Follow EchoIQ into a list and get an email when it puts out news.
Follow EchoIQ